Synchron announced today that it completed its first-in-human brain-computer interface (BCI) implant in the U.S. The procedure, performed at Mount Sinai West in New York, represents the first such implant to occur in the U.S. using an endovascular BCI approach, which does not require invasive open-brain surgery. Dr. Shahram Majidi, assistant professor of neurosurgery, neurology […]
Synchron
Catheter delivery could enable better brain implants: Synchron’s neuroscience chief explains how
Synchron’s catheter delivery could make brain-computer interface technology simpler, safer and more accessible than the leading alternative: open-brain surgery. Officials at Synchron — developer of the catheter-delivered Stentrode brain-computer interface (BCI) implant — believe they’re the only BCI company tapping into blood vessels to capture signals from the brain. They say they’ve already enabled a […]
Synchron says study shows safety of its brain-computer interface implant
Four ALS patients with a Synchron Stentrode brain implant had no serious adverse events one year after their procedure, which allowed the paralyzed patients to control a computer for online shopping, banking and text communication without using their hands or voice for input. New York-based Synchron said this study demonstrated the safety of its brain-computer […]
Synchron touts first-in-human implantation for brain-computer interface
Synchron said today that it completed the first successful clinical implantation of the Stentrode neural interface technology designed to restore communication in people with severe paralysis. The Campbell, Calif.-based company said the minimally invasive neural interface technology, as part of the Synchron brain-computer interface, is in its first clinical feasibility trial. The Stentrode is an […]
Synchron’s thought-to-text tech starts clinical trial
Synchron said it has begun the first clinical trial for its neural interface technology designed to restore communication to people with severe paralysis. The trial will measure the safety of the company’s “thought-to-text” technology by assessing its Stentrode implant in combination with BrainOS software and the stability of high-fidelity signals from the brain to external communications […]
Neural interface developer Synchron raises $10m in Series A
Minimally invasive neuromod developer Synchron said today it raised $10 million in a Series A round of financing to support its neural interface technology. The round was led by Neurotechnology Investors and joined by the U.S. Department of Defense, including the Defense Advanced Research Projects Agency. Campbell, Calif.-based Synchron said that the funds raised will […]